Le Lézard
Classified in: Health, Science and technology
Subjects: TRI, FDA

Integrum's OPRAtm Implant System gets FDA approval for clinical study on below-knee amputations


MÖLNDAL, Sweden, Oct. 30, 2023 /PRNewswire/ -- Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company's OPRAtm Implant system is approved by FDA to be used in a clinical study on below-knee amputations in the US.

The clinical study will be important for the future approval of the OPRAtm Implant System on the below-knee amputation level, which is the most frequent amputation level. The study will be performed by the Walter Reed National Military Medical Center.

"This is an important milestone in the expansion of indications for our OPRAtm Implant System," said Rickard Brĺnemark, CEO of Integrum.

For more information please contact:
Rickard Brĺnemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: [email protected]

Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: [email protected]

Certified Adviser

Erik Penser Bank is Certified Adviser.

The following files are available for download:

https://mb.cision.com/Public/17531/3865375/ae332572d5827e27.pdf

2023-10-30 Integrum PR IDE TTA

 

SOURCE Integrum AB


These press releases may also interest you

at 10:23
O Positiv, the women's health brand breaking taboos, introduces their newest product line, PREGGO Conception Support & Sperm Health Support Capsules....

at 10:21
Powerback Rehabilitation, one of the nation's largest rehabilitation therapy providers, is partnering with the award-winning, earned-wage access platform Tapcheck to offer on-demand access to wages for their 12,000 employees. Tapcheck has partnered...

at 10:15
Jean-Claude Saghbini, President of Value-based Care Enablement and Chief Technology Officer at Lumeris, the market-leading value-based care enablement company, will speak at HIMSS24 with Nicole Harris-Hollingsworth, EdD, MCHES, Vice President, Social...

at 10:10
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the sale of its...

at 10:09
B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, today announced a collaboration agreement with Orlando Health, a nationally recognized healthcare provider with award-winning hospitals, to jointly develop...

at 10:06
Technoclone Herstellung von Diagnostika und Arzneimitteln GmbH, world-leading producer of diagnostic tests, equipment, and research products in the field of blood clotting and its exclusive distributor in the USA, DiaPharma Group, Inc., are pleased...



News published on and distributed by: